Andrew Stewart Plump sold $2.1M of TAK
President, R&D at TAKEDA PHARMACEUTICAL CO LTD. 116,191 shares at an average of $18.49, traded Sep 2, 2026, filed Sep 3, 2026.
Score components
- +20RolePresident
- +25Trade size$2.1M at market
- +10Share of holdings soldSold 44% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001395064-26-000335, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | SOpen-market sale American Depositary Sharesindirect: By Trust10b5-1 | -116,191 | $18.49 | $2.1M | 145,465 | 41 d ago |
Related signals
Other insiders at TAKEDA PHARMACEUTICAL CO LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Lauren Rusckowski Duprey Chief Transformation Officer | $640k 34,535 shares | -15% | |
| 30Weak | TAKEDA PHARMACEUTICAL CO LTD | Andrew Stewart Plump President, R&D | $363k 19,651 shares | -7% | |
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $235k 12,980 shares | -24% | |
| 63Notable | TAKEDA PHARMACEUTICAL CO LTD | Teresa Marie Bitetti President, OBU | $855k 50,012 shares | -17% | |
| 57Moderate | TAKEDA PHARMACEUTICAL CO LTD | Lauren Rusckowski Duprey Chief Transformation Officer | $814k 47,586 shares | -17% | |
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | Awny Samaan Botros Farajallah Chief Medical Officer | $240k 14,006 shares | -11% | |
| 53Moderate | TAKEDA PHARMACEUTICAL CO LTD | Natalie Anne Marie Furney Global General Counsel | $528k 30,868 shares | -13% | |
| 59Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $606k 34,603 shares | -37% | |
| 45Moderate | TAKEDA PHARMACEUTICAL CO LTD | Nicola Deidre Petal Greenway Chief Human Resources Officer | $116k 6,774 shares | -11% | |
| 45Moderate | TAKEDA PHARMACEUTICAL CO LTD | Ramy Riad Ahmed Ibrahim President, PDT BU | $124k 7,277 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.